ストックスクリーナーアプリを入手
2.41
3.88%
0.09
アフターアワーズ：
2.39
-0.02
-0.83%
前日終値:
$2.32
開ける：
$2.35
24時間の取引高:
1.57M
Relative Volume:
0.13
時価総額：
$325.33M
収益：
-
当期純損益:
$-35.47M
株価収益率:
-4.2281
EPS:
-0.57
ネットキャッシュフロー:
$-124.27M
1週間 パフォーマンス:
+2.12%
1か月 パフォーマンス:
-20.98%
6か月 パフォーマンス:
+60.67%
1年 パフォーマンス:
+10.55%
1日の値動き範囲:
$2.35
$2.475
1週間の範囲:
$2.215
$2.59
52週間の値動き範囲:
$0.4603
$7.13
Prokidney Corp Stock (PROK) Company Profile
PROK を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PROK
Prokidney Corp
|
2.41 | 342.88M | 0 | -35.47M | -124.27M | -0.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Prokidney Corp Stock (PROK) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-30 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2024-09-30 | 開始されました | JP Morgan | Neutral |
| 2024-09-10 | 開始されました | Guggenheim | Buy |
| 2024-03-07 | 再開されました | Morgan Stanley | Equal-Weight |
| 2024-01-02 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-07-25 | 開始されました | BTIG Research | Buy |
| 2022-12-21 | 開始されました | Jefferies | Buy |
| 2022-11-10 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-10-18 | 開始されました | UBS | Buy |
| 2022-10-14 | 開始されました | Citigroup | Buy |
| 2022-09-23 | 開始されました | BofA Securities | Buy |
| 2022-09-02 | 開始されました | Evercore ISI | Outperform |
すべてを表示
Prokidney Corp (PROK) 最新ニュース
Trend Dashboard Flags ProKidney Corp. As Potential Swing TradeJuly 2025 Final Week & Weekly Watchlist for Hot Stocks - beatles.ru
Published on: 2025-08-21 03:49:33 - newsyoung.net
PROK Surges More Than 500% on Upbeat Data From Kidney Cell Therapy Study - MSN
Is ProKidney Corp. subject to activist investor interestAnalyst Upgrade & Smart Swing Trading Alerts - newsyoung.net
What are ProKidney Corp.’s recent SEC filings showingJuly 2025 WrapUp & Daily Risk Controlled Trade Plans - thegnnews.com
Chartists Watching For Breakout in ProKidney Corp.Trade Volume Report & Fast Gain Swing Alerts - newsyoung.net
Live Scanner Shows Breakout on ProKidney Corp.Index Update & Weekly High Return Stock Opportunities - metal.it
ProKidney reports Q2 EPS (13c), consensus (14c) - MSN
Meet the Biotech Stock That Rocketed 775% Higher - AOL.com
Is This a Bottoming Phase for ProKidney Corp.July 2025 Pullbacks & Fast Entry Momentum Trade Alerts - sundaytimes.kr
Is ProKidney Corp. forming a bullish divergenceQuarterly Growth Report & Real-Time Chart Breakout Alerts - newsyoung.net
ProKidney reports larger second-quarter loss as key studies continue - Winston-Salem Journal
Citi Reaffirms Their Buy Rating on ProKidney (PROK) - The Globe and Mail
ProKidney Reports 78 Percent Gain in Q2 - sharewise.com
What are the key products or services offered by pro-kidney? - AInvest
ProKidney: Hold Rating Amid Encouraging Developments and Cautious Outlook - TipRanks
ProKidney Corp. Reports Q2 2025 Financial Results - TipRanks
ProKidney Reports Second Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates - GlobeNewswire
ProKidney Q2: Rilparencel eGFR slope improves by 78%, topline PROACT 1 data in Q2 2027. - AInvest
ProKidney's Breakthrough: FDA Backs Fast-Track Path as Kidney Treatment Shows Strong Phase 2 Results - Stock Titan
ProKidney (PROK.O) Sees Sharp Intraday Drop — But No Fundamental Catalyst — What’s Really Behind the Move? - AInvest
ProKidney Shares Double on Strong Phase 2 Data for Kidney Disease Therapy - MSN
ProKidney And 2 Other Penny Stocks To Watch Closely - Yahoo Finance
ProKidney PROK 2025Q2 Earnings Preview Upside Potential on Robust Revenue Growth and Analyst Upgrades - AInvest
What institutional investors are buying ProKidney Corp. stockGet timely alerts on top-performing stocks - Jammu Links News
What is the dividend policy of ProKidney Corp. stockFree Technical Analysis Support - Jammu Links News
Is ProKidney Corp. stock overvalued or undervaluedInvest confidently with market-leading analysis - Jammu Links News
What catalysts could drive ProKidney Corp. stock higher in 2025Free Stock Market Return Analysis - Jammu Links News
What makes ProKidney Corp. stock price move sharplyGet daily updates on top-performing stocks - Jammu Links News
What are the technical indicators suggesting about ProKidney Corp.Get exclusive access to premium stock research - Jammu Links News
What analysts say about ProKidney Corp. stockAchieve triple-digit returns with smart investing - Jammu Links News
What are analysts’ price targets for ProKidney Corp. in the next 12 monthsConsistent high-yield stocks - Jammu Links News
Is ProKidney Corp. a growth stock or a value stockHigh-margin investment plays - Jammu Links News
Is it the right time to buy ProKidney Corp. stockAchieve consistent profits with expert strategies - Jammu Links News
How volatile is ProKidney Corp. stock compared to the marketRapid growth opportunities - Jammu Links News
What are ProKidney Corp. company’s key revenue driversCapitalize on emerging market trends - Jammu Links News
When is ProKidney Corp. stock expected to show significant growthDiscover breakthrough trading strategies - Jammu Links News
How does ProKidney Corp. generate profit in a changing economyUnlock rapid growth potential in your portfolio - Jammu Links News
How does ProKidney Corp. compare to its industry peersHigh-octane investment opportunities await - Jammu Links News
ProKidney Shares Surge in Early Trading On FDA Support for Kidney Drug Trial - 富途牛牛
What is ProKidney Corp. company’s growth strategyAdvanced Screener Planner For 2025 - Jammu Links News
Can ProKidney Corp. Regain Lost Ground This QuarterStep-by-Step Stock Investment Guide Gains Popularity - metal.it
How strong is ProKidney Corp. company’s balance sheetAdvanced Screener Planner For 2025 - jammulinksnews.com
How ProKidney Corp. stock performs during market volatilityWeekly Stock Opportunity Radar Scanner Activated - beatles.ru
Published on: 2025-07-30 17:58:00 - beatles.ru
Published on: 2025-07-29 09:29:22 - metal.it
Wyckoff Accumulation Phase Possible in ProKidney Corp.Buy Low Sell High Stock Watch Strategy in Focus - metal.it
Prokidney Corp (PROK) 財務データ
収益
当期純利益
現金流量
EPS
0.94%
1.72%
大文字化:
|
ボリューム (24 時間):